NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$5.10
-5.90%
Mkt Cap $19.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+194.1%
Consensus $15.00 vs current $5.10
NASDAQ·Healthcare·Biotechnology
$5.10
-5.90%
Mkt Cap $19.58M
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
+194.1%
Consensus $15.00 vs current $5.10